{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:46:21Z","timestamp":1787921181377,"version":"build-2784847793"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The rapid spread of infectious diseases presents a significant global threat, with seasonal influenza viruses, leading to 290,000\u2013650,000 deaths annually. Emerging high pathogenic influenza strains from animals such as H5N1 and H7N9 further exacerbates pandemic risks. While developing effective vaccines and therapeutics is critical, the evaluation of these interventions is constrained by the requirement for high biosafety containment facilities. To circumvent these challenges, we developed S-Lux, a replication-deficient, single-cycle recombinant influenza virus expressing <jats:italic>firefly luciferase<\/jats:italic> (<jats:italic>Flux<\/jats:italic>) as a reporter protein. S-Lux can be pseudotyped with haemagglutinin from avian influenza, H5 and H7, enabling real-time monitoring of viral infection <jats:italic>in vivo<\/jats:italic>, and facilitate therapeutic antibody evaluation in low-containment facilities. In mice, S-Lux infection resulted in dose-dependent bioluminescent expression in the mouse airways and allowed evaluation of neutralising monoclonal antibodies and clearance of infected cells in mice. To extend this system, we generated ES-Lux by pseudotyping with the Ebola Glycoprotein (GP) and demonstrated that ES-Lux can be used to evaluate the efficacy of Ebola GP-targeting antibodies <jats:italic>in vivo<\/jats:italic>. Together, S-Lux and ES-Lux enable robust, simple and time-efficient assessment of antiviral therapy targeting influenza and Ebola virus <jats:italic>in vivo<\/jats:italic>, overcoming biosafety constraints that limit traditional efficacy studies.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1608074","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T04:12:15Z","timestamp":1752120735000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Single-cycle, pseudotyped reporter influenza virus to facilitate evaluation of treatment strategies for avian influenza, Ebola and other highly infectious diseases in vivo"],"prefix":"10.3389","volume":"16","author":[{"given":"Tiong Kit","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramila","family":"Rijal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Ying A.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah R.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain R.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"B1","volume-title":"Influenza (Seasonal) Fact Sheets","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61171-X","article-title":"Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases","volume":"382","author":"Cowling","year":"2013","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2155072","DOI":"10.1080\/22221751.2022.2155072","article-title":"Alarming situation of emerging H5 and H7 avian influenza and effective control strategies","volume":"12","author":"Shi","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30323-7","article-title":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China 2013-17: an epidemiological study of laboratory-confirmed case series","volume":"17","author":"Wang","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"B5","unstructured":"Viruses of Special Concern\n          \n          \n          \n          2023"},{"key":"B6","volume-title":"Laboratory diagnosis of Ebola virus disease","year":"2014"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2008.12.014","article-title":"Animal models for the study of influenza pathogenesis and therapy","volume":"82","author":"Barnard","year":"2009","journal-title":"Antiviral Res"},{"key":"B8","article-title":"Animal models of ebolavirus infection","volume":"67","author":"St Claire","year":"2017","journal-title":"Comp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00969-13","article-title":"In vivo bioluminescent imaging of influenza A virus infection and characterization of novel cross-protective monoclonal antibodies","volume":"87","author":"Heaton","year":"2013","journal-title":"J Virol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/ncomms3369","article-title":"Visualizing influenza virus infection in living mice","volume":"4","author":"Pan","year":"2013","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097695","article-title":"Influenza A virus encoding secreted gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins","volume":"9","author":"Eckert","year":"2014","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6378","DOI":"10.1038\/ncomms7378","article-title":"Visualizing real-time influenza virus infection, transmission and protection in ferrets","volume":"6","author":"Karlsson","year":"2015","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3791\/59890","article-title":"A luciferase-fluorescent reporter influenza virus for live imaging and quantification of viral infection","author":"Chiem","year":"2019","journal-title":"J Vis Exp"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1038\/s41598-022-06667-w","article-title":"Real-time tracking of bioluminescent influenza A virus infection in mice","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01820-12","article-title":"Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity","volume":"86","author":"Powell","year":"2012","journal-title":"J Virol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.virusres.2015.07.013","article-title":"Development and applications of single-cycle infectious influenza A virus (sciIAV)","volume":"216","author":"Nogales","year":"2016","journal-title":"Virus Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1128\/JVI.00941-17","article-title":"Characterization of influenza virus pseudotyped with ebolavirus glycoprotein","volume":"92","author":"Xiao","year":"2018","journal-title":"J Virol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI81104","article-title":"Focused antibody response to influenza linked to antigenic drift","volume":"125","author":"Huang","year":"2015","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001228","article-title":"A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge","volume":"100","author":"Powell","year":"2019","journal-title":"J Gen Virol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01487-15","article-title":"Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge","volume":"6","author":"Baz","year":"2015","journal-title":"MBio"},{"key":"B21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and function analysis of an antibody recognizing all influenza A subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0303-7","article-title":"Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans","volume":"4","author":"Huang","year":"2019","journal-title":"Nat Microbiol"},{"key":"B23","volume-title":"Ebola Situation Report","year":"2016"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.12.6408-6412.2002","article-title":"Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody","volume":"76","author":"Parren","year":"2002","journal-title":"J Virol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/path.4456","article-title":"Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses","volume":"235","author":"Martines","year":"2015","journal-title":"J Pathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2017.08.007","article-title":"A phase 1 study to evaluate the safety and pharmacokinetics of MEDI8852, an anti-influenza A monoclonal antibody, in healthy adult volunteers","volume":"50","author":"Mallory","year":"2017","journal-title":"Biologicals"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix292","article-title":"The hemagglutinin A stem antibody MEDI8852 prevents and controls disease and limits transmission of pandemic influenza viruses","volume":"216","author":"Paules","year":"2017","journal-title":"J Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0123659","DOI":"10.1371\/journal.pone.0123659","article-title":"Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge","volume":"10","author":"Yang","year":"2015","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2017.08.016","article-title":"An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge","volume":"511","author":"Wilson","year":"2017","journal-title":"Virology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.007823","article-title":"The ferret as a model organism to study influenza A virus infection","volume":"4","author":"Belser","year":"2011","journal-title":"Dis Models Mech"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/jb.89.1.170-174.1965","article-title":"Induction of partial specific heterotypic immunity in mice by a single infection with influenza a virus","volume":"89","author":"Schulman","year":"1965","journal-title":"J Bacteriol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.7.6024-6030.1999","article-title":"Ebola virus can be effectively neutralized by antibody produced in natural human infection","volume":"73","author":"Maruyama","year":"1999","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01239-16","article-title":"An ebola virus-like particle-based reporter system enables evaluation of antiviral drugs in vivo under non-biosafety level 4 conditions","volume":"90","author":"Li","year":"2016","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1086\/514292","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","author":"Bray","year":"1999","journal-title":"J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2006.03.006","article-title":"Ebola virus: unravelling pathogenesis to combat a deadly disease","volume":"12","author":"Hoenen","year":"2006","journal-title":"Trends Mol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv284","article-title":"Considerations in the use of nonhuman primate models of ebola virus and marburg virus infection","volume":"212","author":"Geisbert","year":"2015","journal-title":"J Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.11.9679-9682.1999","article-title":"Rescue of influenza A virus from recombinant DNA","volume":"73","author":"Fodor","year":"1999","journal-title":"J Virol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1608074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T04:12:17Z","timestamp":1752120737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1608074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2025.1608074"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1608074","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"article-number":"1608074"}}